{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-25-000059","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2025-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.340812+00:00","generated_at":"2026-05-22T17:04:23.702975+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SI-BONE Q1 revenue up 25% to $47.3M, posts positive adjusted EBITDA, raises FY guidance","bullets":["Worldwide revenue $47.3M, up 24.9% YoY; U.S. revenue $44.8M, up 26.6%.","Gross margin 79.7% vs 78.9% a year ago; net loss improved 40% to $6.5M ($0.15/share).","Adjusted EBITDA positive $0.5M vs loss of $4.0M in Q1 2024; cash $144.4M, net cash usage down 31.7%.","FY2025 revenue guidance raised to $193.5M-$197.5M (prior $193.5M-$195.5M); expects positive adjusted EBITDA for full year.","Added 300 active U.S. physicians in Q1; CMS proposed NTAP for iFuse TORQ TNT up to $3,960/ procedure."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-25-000059","json":"https://secwatch.observer/filing/0001459839-25-000059.json","markdown":"https://secwatch.observer/filing/0001459839-25-000059.md","text":"https://secwatch.observer/filing/0001459839-25-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983925000059/0001459839-25-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983925000059/sibn-20250505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T17:04:23.702975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}